-
EP1225909
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1225909
| EP1225909 - FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.08.2011 Database last updated on 03.09.2024 | Most recent event Tooltip | 26.08.2011 | Application deemed to be withdrawn | published on 28.09.2011 [2011/39] | Applicant(s) | For all designated states THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES The National Institute of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325 Rockville, MD 20852 / US | [N/P] |
| Former [2002/31] | For all designated states THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES c/o National Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325 Rockville, MD 20852-3804 / US | Inventor(s) | 01 /
HANADA, Ken-Ichi 24 Courthouse Square, No 1007 Rockville, MD 20852 / US | 02 /
YANG, James, C. 1 Serpentine Court Silver Spring, MD 20904 / US | [2002/38] |
| Former [2002/31] | 01 /
HANADA, Ken-Ichi 10101 Grosvenor Place, 1209 Rockville, MD 20852 / US | ||
| 02 /
YANG, James, C. 1 Serpentine Court Silver Spring, MD 20904 / US | Representative(s) | Gowshall, Jonathan Vallance Forresters IP LLP Skygarden Erika-Mann-Strasse 11 80636 München / DE | [N/P] |
| Former [2008/44] | Gowshall, Jonathan Vallance Forrester & Boehmert Pettenkoferstrasse 20-22 80336 München / DE | ||
| Former [2002/31] | Gowshall, Jonathan Vallance FORRESTER & BOEHMERT Pettenkoferstrasse 20-22 80336 München / DE | Application number, filing date | 00968465.5 | 29.09.2000 | [2002/31] | WO2000US26689 | Priority number, date | US19990157103P | 02.10.1999 Original published format: US 157103 P | [2002/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0125271 | Date: | 12.04.2001 | Language: | EN | [2001/15] | Type: | A2 Application without search report | No.: | EP1225909 | Date: | 31.07.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.04.2001 takes the place of the publication of the European patent application. | [2002/31] | Search report(s) | International search report - published on: | EP | 10.05.2002 | Classification | IPC: | A61K38/18, C07K14/50, A61K39/395, C07K16/22 | [2002/31] | CPC: |
A61K39/39 (EP);
A61K2239/46 (EP,US);
A61K39/4611 (EP,US);
A61K39/464432 (EP,US);
A61P13/12 (EP);
A61P35/00 (EP);
C07K14/50 (EP);
A61K2039/53 (EP);
A61K2039/55516 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/31] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | FIBROBLASTEN-WACHSTUMSFAKTOR 5 (FGF-5) IST EIN TUMORASSOZIERTES T-ZELL-ANTIGEN | [2002/31] | English: | FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN | [2002/31] | French: | FACTEUR DE CROISSANCE DES FIBROBLASTES 5 (FGF-5) DANS UN ANTIGENE DE LEUCOCYTE T ASSOCIE AUX TUMEURS | [2002/31] | Entry into regional phase | 25.04.2002 | National basic fee paid | 25.04.2002 | Designation fee(s) paid | 25.04.2002 | Examination fee paid | Examination procedure | 30.04.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 25.04.2002 | Examination requested [2002/31] | 27.04.2006 | Despatch of a communication from the examining division (Time limit: M04) | 06.09.2006 | Reply to a communication from the examining division | 01.04.2011 | Application deemed to be withdrawn, date of legal effect [2011/39] | 10.05.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2011/39] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.04.2006 | Fees paid | Renewal fee | 23.09.2002 | Renewal fee patent year 03 | 24.09.2003 | Renewal fee patent year 04 | 23.09.2004 | Renewal fee patent year 05 | 21.09.2005 | Renewal fee patent year 06 | 27.09.2006 | Renewal fee patent year 07 | 26.09.2007 | Renewal fee patent year 08 | 25.09.2008 | Renewal fee patent year 09 | 25.09.2009 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 30.09.2010 | 11 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]JPH1017599 ; | [X]WO9012597 (SALK INST FOR BIOLOGICAL STUDI [US]); | [XP]WO9955861 (EISAI CO LTD [JP]); | [XP]WO0024756 (HUMAN GENOME SCIENCES INC [US], et al); | Examination | WO9420125 | WO9515176 | WO9730155 | WO9945952 |